Skip to content
ppharmaranks
Menu

drospirenone

Pharmaranks rates Drospirenone 3.1/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Drospirenone is a medication supplied as a tablet, chewable and tablet.

Generic · by Lupin

62/100Limited · 1 source

Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate
Verified againstopenFDANIH DailyMedRxClass

Key facts

Active ingredient
Drospirenone
Form
Tablet, chewable, Tablet
Strength
Drospirenone 4MG
Type
Prescription (Rx)
Brand or generic
Generic
Manufacturer
Lupin
FDA application
ANDA216936
Availability
Discontinued (per FDA)

Dosage forms

Tablet, chewable and Tablet

The forms currently marketed in the U.S., per the FDA National Drug Code Directory.

Ways to save

Ask for the generic

Same active ingredient, far cheaper. Is there a generic? →

Request a 90-day supply

Bulk fills usually lower the per-dose price vs monthly refills.

Use copay cards

Manufacturer copay cards & patient-assistance programs — especially for brand drugs.

Compare alternatives

A same-class option may cost less. See alternatives →

Frequently asked questions

How is Drospirenone rated?
pharmaranks gives Drospirenone a composite score of 3.1 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
Is there a coupon or discount for Drospirenone?
pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Drospirenone. To pay less, Drospirenone is already a generic — usually the lowest-cost version — so the main levers are comparing cash prices between pharmacies and using a pharmacy discount-card service. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
Who makes Drospirenone?
Drospirenone is marketed by Lupin. You can see Lupin's full profile, rating, and other products on pharmaranks.
Is Drospirenone a brand-name or generic drug?
Drospirenone is a generic medication; its active ingredient is Drospirenone. Generics contain the same active ingredient as the brand-name original and are usually lower cost.
Is Drospirenone available over the counter?
No. Drospirenone is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
What forms does Drospirenone come in?
Drospirenone is currently marketed as tablet, chewable and tablet, per the FDA's National Drug Code Directory.
Is Drospirenone FDA-registered?
Drospirenone is on record with the U.S. FDA under application number ANDA216936. You can verify this on its official FDA label.
Has Drospirenone been recalled by the FDA?
Drospirenone has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
Is Drospirenone safe?
There's no single safe-or-not verdict. pharmaranks gives Drospirenone a recall-safety score of 62/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.

Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.

What people report to the FDA about Drospirenone

The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 6,337 reports naming Drospirenone, and the FDA flagged 83% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:

  • injury1,313 reports
  • cholecystitis chronic1,037 reports
  • pulmonary embolism945 reports
  • anxiety865 reports
  • deep vein thrombosis812 reports
  • gallbladder disorder792 reports
  • cholelithiasis715 reports
  • emotional distress699 reports

Read these as a signal, not a rate. A report does not mean Drospirenone caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.

Source: openFDA drug/event (FAERS), retrieved September 25, 2026.

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

People also viewed

Compare Drospirenone head-to-head

Identify a pill by its imprint →Check a drug interaction →Drug recalls →

Browse medications A–Z

Research products from A to Z, compare independent ratings, and find alternatives.

drospirenone

62/100